Difference between revisions of "Walkey AJ, et al, Chest (2014), cited as Ref 34 in DOI: 10.1007/s11886-020-01293-2 (Q11028)"
Jump to navigation
Jump to search
(Created claim: Published In Name String (P102): Chest, #quickstatements; #temporary_batch_1592836225919) |
(Created claim: DOI Identifier (P138): 10.1378/chest.14-0003, #quickstatements; #temporary_batch_1592836326594) |
||
| Property / DOI Identifier | |||
| + | |||
| Property / DOI Identifier: 10.1378/chest.14-0003 / rank | |||
| + | Normal rank | ||
Revision as of 14:33, 22 June 2020
Cited in: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Walkey AJ, et al, Chest (2014), cited as Ref 34 in DOI: 10.1007/s11886-020-01293-2
|
Cited in: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
|
Statements
Long-term outcomes following development of new-onset atrial fibrillation during sepsis (English)
0 references
2014
0 references
Walkey AJ
0 references
Hammill BG
0 references
Curtis LH
0 references
Benjamin EJ
0 references
Chest
0 references
